Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation

NCT00591630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large Cell Lymphoma
Lymphoma

Interventions

DRUG: Zevalin
DRUG: Carmustine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan
DRUG: Rituximab
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center